VTVT

vTv Therapeutics Inc. Class A Common Stock

34.94

USD

VTVT Earnings Reports

Positive Surprise Ratio

VTVT beat 21 of 34 last estimates.

62%

Next Report

Date of Next Report

Mar 18, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$1.10

Implied change from Q3 25 (Revenue/ EPS)

+1.85%

Implied change from Q4 24 (Revenue/ EPS)

-100.00%

+100.00%

vTv Therapeutics Inc. Class A Common Stock earnings per share and revenue

On Nov 06, 2025, VTVT reported earnings of -1.08 USD per share (EPS) for Q3 25, missing the estimate of -0.99 USD, resulting in a -8.04% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.16% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 5 analysts forecast an EPS of -1.10 USD, with revenue projected to reach -- USD, implying an increase of 1.85% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

FAQ

What were vTv Therapeutics Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, vTv Therapeutics Inc. Class A Common Stock reported EPS of -$1.08, missing estimates by -8.04%, and revenue of $0.00, 0% as expectations.

How did the market react to vTv Therapeutics Inc. Class A Common Stock's Q3 2025 earnings?

The stock price moved up 2.16%, changed from $25.47 before the earnings release to $26.02 the day after.

When is vTv Therapeutics Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Mar 18, 2026.

What are the forecasts for vTv Therapeutics Inc. Class A Common Stock's next earnings report?

Based on 5 analysts, vTv Therapeutics Inc. Class A Common Stock is expected to report EPS of -$1.10 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.